R. 1. Gaulard, P. Bourquelot, P. Kanavaros, and P. , Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas, Am J Pathol, vol.137, pp.617-628, 1990.

J. Farcet, P. Gaulard, and J. Marolleau, Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta, Blood, vol.75, pp.2213-2219, 1990.

C. Cooke, L. Krenacs, and M. Stetler-stevenson, Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin, Blood, vol.88, pp.4265-4274, 1996.

K. Belhadj, F. Reyes, and J. Farcet, Hepatosplenic ???? T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients, Blood, vol.102, issue.13, pp.4261-4269, 2003.
DOI : 10.1182/blood-2003-05-1675

A. Mackey, L. Green, L. Liang, P. Dinndorf, and M. Avigan, Hepatosplenic T Cell Lymphoma Associated With Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.44, issue.2, pp.265-267, 2007.
DOI : 10.1097/MPG.0b013e31802f6424

W. Macon, M. Williams, J. Greer, and J. Cousar, Paracortical Nodular T-Cell Lymphoma, The American Journal of Surgical Pathology, vol.19, issue.3, pp.297-303, 1995.
DOI : 10.1097/00000478-199503000-00007

F. Suarez, I. Wlodarska, and F. Huguet, Hepatosplenic ???? T-Cell Lymphoma, The American Journal of Surgical Pathology, vol.24, issue.7, pp.1027-1032, 2000.
DOI : 10.1097/00000478-200007000-00016

S. Swerdlow, E. Campo, and N. Harris, WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008.

I. Wlodarska, N. Martin-garcia, and R. Achten, Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression, Genes, Chromosomes and Cancer, vol.113, issue.10 suppl. 1, pp.243-251, 2002.
DOI : 10.1002/gcc.10021

M. Bennett, E. Matutes, and P. Gaulard, Hepatosplenic T cell lymphoma responsive to 2???-deoxycoformycin therapy, American Journal of Hematology, vol.85, issue.9, pp.727-729, 2010.
DOI : 10.1002/ajh.21774

L. De-leval, D. Rickman, and C. Thielen, The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets, Blood. J Clin Invest, vol.109117, issue.12, pp.4952-4963823, 2007.

J. Iqbal, D. Weisenburger, and A. Chowdhury, Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic ???? T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro, Leukemia, vol.2, issue.2, pp.348-358, 2011.
DOI : 10.1016/j.ceb.2006.08.016

Y. Huang, A. De-reynies, and L. De-leval, Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type, Blood, vol.115, issue.6, pp.1226-1237, 2010.
DOI : 10.1182/blood-2009-05-221275

URL : https://hal.archives-ouvertes.fr/inserm-00462629

J. Iqbal, D. Weisenburger, and T. Greiner, Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma, Blood, vol.115, issue.5, pp.1026-1036, 2010.
DOI : 10.1182/blood-2009-06-227579

B. Ballester, O. Ramuz, and C. Gisselbrecht, Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas, Oncogene, vol.89, issue.10, pp.1560-1570, 2006.
DOI : 10.1186/gb-2003-4-4-r28

K. Miyazaki, M. Yamaguchi, and H. Imai, Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas Correia DV, d'Orey F, Cardoso BA, et al. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk-and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders, Blood. Blood. J Clin Invest. PLoS One. Hematology, vol.1139287415, issue.20, pp.1071-10743376, 1991.

D. Noto, R. Pane, F. Camera, and A. , Characterization of two novel cell lines

W. Lim and A. Grunn, derived from a single patient with CD56+ non-Hodgkin's lymphoma Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma, Leukemia. Compagno M Nature, vol.15459, issue.23, pp.1641-1649717, 2001.

G. Caron, L. Gallou, S. Lamy, T. Tarte, K. Fest et al., CXCR4 Expression Functionally Discriminates Centroblasts versus Centrocytes within Human Germinal Center B Cells, The Journal of Immunology, vol.182, issue.12, pp.7595-7602, 2009.
DOI : 10.4049/jimmunol.0804272

URL : https://hal.archives-ouvertes.fr/inserm-00869387

M. Travert, P. Ame-thomas, and C. Pangault, CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL Stimulated gammadelta T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer, J Immunol. J Immunol, vol.181187, pp.1031-1038, 2008.

C. Jenne, A. Enders, and R. Rivera, T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma, J Exp Med. Oncogene, vol.20612, issue.28, pp.2469-24812527, 1996.

W. Zhao, Y. Liu, and Q. Zhang, PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor, Blood, vol.111, issue.7, pp.3867-3871, 2008.
DOI : 10.1182/blood-2007-08-108654

J. Iqbal, C. Kucuk, and R. Deleeuw, Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies, Leukemia, vol.2, issue.6, pp.1139-1151, 2009.
DOI : 10.1038/leu.2009.3

A. Feldman, D. Sun, and M. Law, Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity, Int J Cancer. Leukemia. Blood, vol.12522101, issue.33, pp.1985-19911139, 2003.

W. Morice, W. Macon, A. Dogan, C. Hanson, and P. Kurtin, NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis The biology of NKT cells, Leukemia. Annu Rev Immunol, vol.2025, issue.35, pp.883-886297, 2006.

J. Kelsen, A. Dige, and H. Schwindt, Infliximab induces clonal expansion of gammadelta- T cells in Crohn's disease: a predictor of lymphoma risk? PLoS One Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate, Science, vol.6316, pp.295-298, 2007.

T. Walzer, L. Chiossone, and J. Chaix, Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor, Nature Immunology, vol.168, issue.12, pp.1337-1344, 2007.
DOI : 10.1038/ni1523

URL : https://hal.archives-ouvertes.fr/hal-00297257

J. Marie, Drug resistance in hematologic malignancies, Current Opinion in Oncology, vol.13, issue.6, pp.463-469, 2001.
DOI : 10.1097/00001622-200111000-00008

C. Andreadis, P. Gimotty, and P. Wahl, Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma, Blood, vol.109, issue.8, pp.3409-3416, 2007.
DOI : 10.1182/blood-2006-09-047621

B. Wang, X. Li, X. Ma, X. Hong, H. Lu et al., Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type, American Journal of Hematology, vol.68, issue.10, pp.795-799, 2008.
DOI : 10.1002/ajh.21256

A. Michelutti, M. Michieli, and D. Damiani, Effect of fludarabine and arabinosylcytosine on multidrug resistant cells, Haematologica, vol.82, pp.143-147, 1997.

K. Tew, Glutathione-Associated Enzymes In Anticancer Drug Resistance, Cancer Research, vol.76, issue.1, pp.4313-4320, 1994.
DOI : 10.1158/0008-5472.CAN-15-3143

V. Ribrag, S. Koscielny, and I. Carpiuc, Prognostic value of GST-?? expression in diffuse large B-cell lymphomas, Leukemia, vol.17, issue.5, pp.972-977, 2003.
DOI : 10.1038/sj.leu.2402930

A. Bennaceur-griscelli, J. Bosq, and S. Koscielny, High Level of Glutathione-S-Transferase ?? Expression in Mantle Cell Lymphomas, Clinical Cancer Research, vol.10, issue.9, pp.3029-3034, 2004.
DOI : 10.1158/1078-0432.CCR-03-0554

C. Kucuk, J. Iqbal, and X. Hu, PRDM1 is a tumor suppressor gene in natural killer cell malignancies, Proceedings of the National Academy of Sciences, vol.108, issue.50, p.47, 2011.
DOI : 10.1073/pnas.1115128108

URL : https://hal.archives-ouvertes.fr/inserm-00656367

S. Pogue, T. Kurosaki, J. Bolen, R. Herbst, M. Gururajan et al., B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth, J Immunol. J Immunol, vol.165178, issue.48, pp.1300-1306111, 2000.

R. Wilcox, D. Sun, A. Novak, A. Dogan, S. Ansell et al., Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines, Leukemia, vol.181, issue.1, pp.229-232, 2010.
DOI : 10.1158/0008-5472.CAN-07-0331

J. Friedberg, J. Sharman, and J. Sweetenham, Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia, Blood, vol.115, issue.13, pp.2578-2585, 2010.
DOI : 10.1182/blood-2009-08-236471